R-mabHDI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for R-mabHDI, covering 2011-07-20 to 2011-07-20. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma [Phase 3]